Covered recipient · General Payments record
CHIANTALL ANNE PARAS GIL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,891.10
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,178.97 | 45 |
| Education | $99.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $154.12 | 3 |
| Merck Sharp & Dohme Corporation | $143.58 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $116.68 | 4 |
| Celgene Corporation | $89.96 | 3 |
| Janssen Biotech, Inc. | $57.16 | 1 |
| Genentech USA, Inc. | $55.74 | 2 |
| Karyopharm Therapeutics Inc. | $53.57 | 2 |
| SERVIER PHARMACEUTICALS LLC | $49.93 | 2 |
| Aadi Bioscience, Inc. | $48.92 | 2 |
| Daiichi Sankyo Inc. | $41.39 | 2 |
| Coherus Biosciences Inc. | $41.17 | 2 |
| JAZZ PHARMACEUTICALS INC. | $39.55 | 1 |
| EMD Serono, Inc. | $36.10 | 1 |
| PFIZER INC. | $35.47 | 1 |
| Gilead Sciences, Inc. | $33.49 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $29.99 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $29.89 | 1 |
| Blueprint Medicines Corporation | $27.62 | 1 |
| Incyte Corporation | $26.16 | 1 |
| EISAI INC. | $24.20 | 1 |
| ABBVIE INC. | $21.70 | 1 |
| Deciphera Pharmaceuticals Inc. | $20.81 | 1 |
| Astellas Pharma US Inc | $19.82 | 1 |
| Acerta Pharma LLC | $17.26 | 1 |
| Ipsen Biopharmaceuticals, Inc | $16.98 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.93 | 1 |
| Alnylam Pharmaceuticals Inc. | $15.83 | 1 |
| Immunocore Limited | $14.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (46)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.